Neoadjuvant Pazopanib Treatment in High-Risk Soft Tissue Sarcoma: A Quantitative Dynamic ¹⁸F-FDG PET/CT Study of the German Interdisciplinary Sarcoma Group

Por Christos Sachpekidis, Ioannis Karampinis, Jens Jakob, Bernd Kasper, Kai Nowak, Lothar Pilz, Ulrike Attenberger, Timo Gaiser, Hans-Günter Derigs, Matthias Schwarzbach, Peter Hohenberger, Antonia Dimitrakopoulou-Strauss, Ulrich Ronellenfitsch
Publicado em 2019-06-01